XERS Tingkat bathi reged Xeris Biopharma Inc

Lambang korporat lan logo Xeris Biopharma Holdings, Inc. (XERS)

Reliable injection delivery via temperature control ensures therapy readiness, and the base chart on GURU.Markets contains the gross profit percentage, where the latest parameter is 84.40. The Xeris Biopharma (XERS) model is based on alliances with biotech laboratories to create new formulas, while the company relies on standard environmental regulations for waste disposal and energy conservation.

Xeris Biopharma (XERS): Margin reged saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Xeris Biopharma Holdings, Inc. (XERS)

Analisis dhasar perusahaan:Xeris Biopharma Holdings (XERS)
Produk merek Xeris Biopharma Holdings

Gross margin measures production efficiency by determining the portion of revenue remaining after covering direct costs of goods sold. The trend in gross margin allows investors to assess the pricing power of Xeris Biopharma (XERS) in the sale of specialized injection systems for patients with endocrine pathologies, whose expenses are covered by insurance payments.